Exhaled Breath Condensate Biomarkers in CARAS
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHenan University of Traditional Chinese Medicine
About this trial
To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a more simple, direct and objective way. To screen the biomarkers that can be identified by CARAS Chinese medicine symptoms and different stages, and to provide a reference basis for individualised diagnosis and treatment of the disease.
Eligibility criteria
Qualifiers
Patients with AR, BA and CARAS who meet the Western medical diagnostic criteria;
Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence, or wind-heat offending the lung evidence;
Age 18 to 80 years;
Voluntarily accepted the study and signed an informed consent form;
Disqualifiers
Patients with combined vasomotor rhinitis and eosinophilic non-allergic rhinitis, other non-allergic rhinitis diseases that can cause symptoms such as nasal congestion and runny nose;
Patients who are participating in other drug trials;
Patients with a combination of other serious systemic diseases;
Pregnant or lactating women;
Trial design
Treatments tested in this trial
- questionnaire survey
Treatment groups
270 Participants
are divided into 9 treatment groups9
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov